NGS & Sequencing Published: July 23, 2026 By VigyanLLM Research Team

Amplicon Sequencing — What It Is, How It Works & When to Use It

Amplicon sequencing combines PCR amplification with next-generation sequencing to achieve deep, cost-effective coverage of target genomic regions. A complete guide to the technology, workflow, applications, and primer design.

What is amplicon sequencing?

Amplicon sequencing is a targeted next-generation sequencing (NGS) method that uses PCR to amplify specific genomic regions of interest before sequencing. By multiplexing hundreds or thousands of primer pairs in a single reaction, it enriches target loci and achieves deep coverage (500-10,000x) at a fraction of the cost of whole-genome sequencing.

What Is Amplicon Sequencing?

Amplicon sequencing is a targeted sequencing approach where specific genomic regions are first amplified by PCR, then sequenced on a next-generation sequencing (NGS) platform. The amplified DNA fragments — called amplicons — represent only the loci of interest, making this method highly efficient when you need deep coverage of selected genes or genomic regions.

The key innovation of amplicon sequencing is multiplex PCR: dozens to thousands of primer pairs are pooled in a single reaction, each pair amplifying a different target region. After PCR, the pooled amplicon library is sequenced on Illumina, Ion Torrent, or Nanopore platforms. The result is a sequencing dataset focused entirely on the regions you care about, with none of the sequencing budget spent on irrelevant genomic regions.

Key Concept

An amplicon is any DNA fragment produced by PCR amplification. In amplicon sequencing, each amplicon is defined by a specific primer pair that binds to flanking conserved regions, ensuring that only your selected genomic loci are amplified and sequenced.

How Amplicon Sequencing Works: Step-by-Step Workflow

1. Primer Panel Design

The most critical step. A panel of primers is designed to amplify all target regions. Each primer pair must have similar melting temperatures (58-62°C), minimal cross-dimerization with other primers in the pool, and amplicon sizes appropriate for the sequencing platform (150-300 bp for Illumina, 200-1000 bp for Ion Torrent). Tools like VigyanLLM's automated primer design can design balanced multiplex panels.

2. Library Preparation

Genomic DNA or cDNA is extracted and quantified. Multiplex PCR is performed in one or two pools using the primer panel. Adapter sequences (containing platform-specific sequencing primers and index barcodes) are added either through tailed primers or during a second PCR. The library is purified using AMPure beads or column-based cleanup.

3. Quantification & Pooling

Each sample library is quantified by qPCR or fluorometry. Libraries are normalized and pooled at equimolar concentrations. The final pooled library is denatured and diluted to the optimal loading concentration for the sequencing platform.

4. Sequencing

The pooled library is sequenced on an Illumina (MiSeq, NextSeq, NovaSeq), Ion Torrent (S5, GeneStudio), or long-read platform. Read length depends on amplicon size: 2x150 bp paired-end reads are standard for amplicons up to 200 bp; 2x300 bp for longer amplicons up to 600 bp.

5. Data Analysis

Raw reads are demultiplexed by index, adapter-trimmed, and quality-filtered. Reads are aligned to the reference genome or assembled de novo. Variants are called, annotated, and filtered. For 16S amplicon sequencing, reads are classified taxonomically against reference databases like SILVA or Greengenes.

Amplicon Sequencing vs Other NGS Methods

Feature	Amplicon Sequencing	Whole-Genome Sequencing	Capture-Based Sequencing
Coverage depth	500-10,000x on target	15-30x typical	100-500x on target
Target region size	Up to 5 Mb (multiplex PCR)	3 Gb (human genome)	1-100 Mb
Cost per sample	Lowest ($20-100)	Highest ($500-2000)	Moderate ($100-500)
Turnaround time	1-2 days	3-7 days	3-5 days
GC bias	High (PCR-dependent)	Low	Moderate
Allele dropout risk	Present (primer mismatch)	None	Low
Structural variant detection	Poor	Excellent	Moderate
DNA input requirement	1-10 ng	100-1000 ng	50-200 ng

Key Applications of Amplicon Sequencing

16S rRNA Metagenomics (Microbiome Analysis)

The most widespread application. Conserved regions (V1-V9 hypervariable regions) of the 16S ribosomal RNA gene are amplified from mixed microbial DNA samples. The resulting sequences are classified against reference databases to profile the taxonomic composition of bacterial communities. This approach is used in gut microbiome research, environmental microbiology, and clinical infectious disease diagnostics.

Targeted Cancer Gene Panels

Comprehensive panels targeting 50-500 oncogenes and tumor suppressor genes (e.g., TP53, KRAS, EGFR, BRAF, PIK3CA) are used for somatic mutation profiling in solid tumors and liquid biopsies. The high depth (1000x+) enables detection of low-frequency mutations down to 1-5% variant allele frequency, which is critical for early cancer detection and monitoring minimal residual disease.

Inherited Disease Mutation Screening

Amplicon panels targeting genes associated with specific genetic disorders (cardiomyopathy, hereditary cancer syndromes, neurogenetic disorders) enable rapid, cost-effective screening of multiple patients. The targeted approach avoids incidental findings common in WGS.

Viral Whole-Genome Sequencing

Amplicon-based approaches are the method of choice for sequencing RNA viruses like SARS-CoV-2, influenza, HIV, and hepatitis viruses. Tiling primer sets spanning the entire viral genome are used to amplify overlapping fragments. This method enabled global SARS-CoV-2 surveillance during the pandemic and continues to be critical for monitoring emerging variants.

HLA Typing

Amplicon sequencing of HLA genes (HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, HLA-DPB1) provides high-resolution genotyping for transplant matching, autoimmune disease research, and pharmacogenomics. The method can resolve ambiguous alleles and identify novel variants.

Primer Design for Amplicon Sequencing Panels

Designing a multiplex amplicon panel requires careful optimization. Follow these guidelines:

Amplicon size: 150-300 bp for optimal Illumina sequencing (shorter amplicons cluster more efficiently). For Ion Torrent, 200-400 bp is standard. For long-read platforms, amplicons can be 1-10 kb.
Primer Tm: 58-62°C with less than 2°C variation across the panel. Uniform annealing temperature is essential for balanced multiplex amplification.
GC content: 40-60% with no runs of 4+ identical bases at the 3' end.
Cross-dimerization: Minimize 3' complementarity between any two primers in the pool. Software tools perform pairwise alignment of all primers to flag problematic interactions.
Exon-exon spanning: For RNA targets (e.g., fusion gene detection), design primers across exon-exon junctions to avoid genomic DNA amplification.
Tiling density: Overlap adjacent amplicons by 20-50 bp to ensure coverage of regions near primer binding sites that may have poor read depth.

Use VigyanLLM's automated primer design tool to design balanced multiplex panels with 22-step validation, Tm optimization, and cross-dimerization checking.

Pro Tip: Panel Balancing

Uneven amplification is the most common problem in amplicon sequencing panels. If some amplicons amplify poorly, adjust primer concentrations (increase for low-performers, decrease for over-performers) rather than redesigning primers. Use qPCR or a test sequencing run to assess balance before scaling up.

Limitations of Amplicon Sequencing

Amplicon sequencing has important limitations. PCR bias leads to underrepresentation of GC-rich or GC-poor regions. Allele dropout occurs when a primer-binding site contains a variant, causing one allele to amplify preferentially — this is particularly problematic for clinical mutation detection. Limited target region (typically up to 5 Mb with multiplex PCR) means amplicon panels cannot scale to exome or genome-sized targets. Primer-dimer artefacts waste sequencing capacity and reduce on-target rates. Finally, structural variants (large deletions, duplications, inversions) are poorly detected because the PCR step disrupts breakpoint-spanning information.

Amplicon Sequencing vs qPCR: Different Tools, Different Jobs

While both use PCR amplification, amplicon sequencing and qPCR serve different purposes. qPCR quantifies a single target (or a few targets in multiplex) with high precision and low cost, but cannot discover new variants. Amplicon sequencing simultaneously analyzes hundreds to thousands of targets and detects all variants within those regions (known and novel), but at higher cost. For routine clinical testing of known mutations, qPCR remains the workhorse. For discovery, surveillance, and comprehensive profiling, amplicon sequencing is preferred.

Design Amplicon Sequencing Panels with VigyanLLM

Use VigyanLLM free automated primer design for NGS amplicon panels. Automatically balance multiplex primer pools, validate specificity with BLAST, optimize Tm for 58-62°C, and detect cross-dimerization.

Design Primers Free →

About the Author — VigyanLLM Research Team

The VigyanLLM Research Team combines expertise in molecular biology, bioinformatics, and software engineering to build sovereign computational biology tools for researchers worldwide. Our team develops advanced primer design algorithms and NGS analysis pipelines at VigyanLLM.

Frequently Asked Questions

What is amplicon sequencing?

Amplicon sequencing is a targeted next-generation sequencing method that uses PCR to amplify specific genomic regions before sequencing. It enriches target regions by multiplex PCR, enabling deep sequencing of selected loci at lower cost than whole-genome sequencing.

What is the difference between amplicon sequencing and whole-genome sequencing?

Amplicon sequencing targets specific genomic regions by PCR, while WGS sequences the entire genome. Amplicon sequencing is cheaper, faster, and achieves higher depth (1000x+) on target regions but only covers preselected loci. WGS provides unbiased coverage of the entire genome at lower depth (30x typical).

How do you design primers for amplicon sequencing panels?

Primers for amplicon sequencing should have Tm 58-62°C, amplicon size 150-300 bp for Illumina or 200-1000 bp for Ion Torrent, minimal cross-dimerization between primer pairs, and uniform Tm across the panel. Primers should span exon-exon junctions for RNA targets.

What is amplicon sequencing used for?

Amplicon sequencing is used for 16S rRNA metagenomics (microbiome analysis), targeted cancer gene panels, inherited disease mutation screening, viral whole-genome sequencing, HLA typing, and liquid biopsy ctDNA detection.

What is the difference between amplicon and capture-based sequencing?

Amplicon sequencing uses PCR to amplify target regions with primers. Capture-based sequencing uses hybridization probes to enrich targets from a DNA library. Amplicon is faster and cheaper but prone to PCR bias and allele dropout. Capture provides more uniform coverage and can target larger regions (up to 100 Mb).

What are the limitations of amplicon sequencing?

Key limitations include PCR bias (GC-rich regions may underamplify), allele dropout from primer-binding site mismatches, limited target region size compared to capture-based methods, primer-dimer artefacts, and inability to detect structural variants or repeat expansions.

What depth should I target for amplicon sequencing?

The required depth depends on the application: 500-1000x for SNV detection in solid tumors, 5000x+ for ctDNA liquid biopsy, and 10000x+ for rare variant detection below 1% allele frequency. Higher depth improves sensitivity but increases cost. Most amplicon panels achieve 500-2000x mean depth across targeted regions.

How long are typical amplicon sequencing reads?

For Illumina platforms, amplicon size is typically 150-300 bp with paired-end reads of 150-300 bp. For Ion Torrent, amplicons range from 200-1000 bp. The amplicon size must match the sequencing platform's read length capability, and overlapping paired-end reads improve variant calling accuracy.

Can amplicon sequencing detect structural variants?

Amplicon sequencing has limited capability for structural variant detection because PCR amplification destroys breakpoint information. Structural variants, copy number changes, and repeat expansions are better detected by whole-genome sequencing or specific capture-based methods designed for SV detection.

What is PCR bias in amplicon sequencing?

PCR bias occurs when certain amplicons amplify more efficiently than others due to GC content, secondary structure, or primer efficiency differences. This leads to uneven coverage across targets. GC-rich regions typically underamplify, while GC-balanced regions amplify well. Multiplex PCR optimization and unique molecular identifiers (UMIs) help reduce bias.

How do I design a multiplex amplicon panel?

Design primers with uniform Tm (58-62°C), amplicon sizes within a narrow range (150-200 bp for Illumina), minimal cross-dimerization, and no stable secondary structures. Use primer design software with multiplex compatibility checking. Test primer pools in small batches before full panel assembly.

What is the role of UMIs in amplicon sequencing?

Unique Molecular Identifiers (UMIs) are random oligonucleotide barcodes attached to each DNA molecule before PCR amplification. UMIs allow bioinformatic removal of PCR duplicates and polymerase errors by grouping reads with the same UMI. This significantly improves variant detection accuracy, especially for low-frequency variants below 5% allele frequency.

Why This Matters for Amplicon Sequencing

Understanding amplicon sequencing is essential for molecular biology researchers, clinical genomics laboratories, and biotechnology professionals. The choice between amplicon, capture, and WGS methods has major implications for data quality, cost, and time to results. Accurate primer panel design directly impacts sequencing success. VigyanLLM automates these workflows with comprehensive biophysical validation and multiplex panel balancing.

References

Quail M.A. et al. (2012). A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 13, 341.
Bybee S.M. et al. (2011). Targeted amplicon sequencing (TAS): a scalable next-gen approach to multilocus, multitaxa phylogenetics. Genome Biology and Evolution, 3, 1317-1323.
Samorodnitsky E. et al. (2015). Evaluation of hybridization capture versus amplicon-based methods for whole-exome sequencing. Human Mutation, 36(9), 903-914.
Hodkinson B.P. & Grice E.A. (2015). Next-generation sequencing: a review of technologies and tools for wound microbiome research. Advances in Wound Care, 4(1), 50-58.
Meredith M.M. et al. (2012). Dramatic enhancement of HIV-1 detection by whole genome amplicon sequencing. Journal of Virological Methods, 179(1), 214-221.